Tasimelteon Capsule
Product Images NDC 69238-2548

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tasimelteon (NDC 69238-2548). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Tasimelteon Capsules 20 mg 1)

FDA Label Image

1 (Tasimelteon Capsules 20 mg 2)

1 (Tasimelteon Capsules 20 mg 2)
This is a medication label for Tasimelteon, which is available in capsules. Each capsule contains 20 mg of the medication and it is usually taken before bedtime at the same time every night without food. The medication should be stored at a controlled room temperature between 20 to 25°C and excursions of 15 to 80°C are permitted. It should be kept in the original container and protected from light and moisture, and out of reach of children. Tasimelteon is distributed by Vanda Pharmaceuticals LLC and the label was last revised in 2023.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.